| Year |
Citation |
Score |
| 2024 |
Pereira SC, Coeli-Lacchini FB, Pereira DA, Ferezin LP, Menezes IC, Baes CVW, Luizon MR, Juruena MF, Cleare AJ, Young AH, Lacchini R. Early life stress unravels epistatic genetic associations of cortisol pathway genes with depression. Journal of Psychiatric Research. 175: 323-332. PMID 38759498 DOI: 10.1016/j.jpsychires.2024.05.032 |
0.329 |
|
| 2024 |
Ko K, Kopra EI, Cleare AJ, Rucker JJ. Corrigendum to "Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis". [J. Affect. Disord., 322 (2023), 194-204]. Journal of Affective Disorders. PMID 38184476 DOI: 10.1016/j.jad.2023.10.159 |
0.348 |
|
| 2023 |
Jauhar S, Arnone D, Baldwin DS, Bloomfield M, Browning M, Cleare AJ, Corlett P, Deakin JFW, Erritzoe D, Fu C, Fusar-Poli P, Goodwin GM, Hayes J, Howard R, Howes OD, et al. A leaky umbrella has little value: evidence clearly indicates the serotonin system is implicated in depression. Molecular Psychiatry. PMID 37322065 DOI: 10.1038/s41380-023-02095-y |
0.361 |
|
| 2023 |
Nettis MA, Lombardo G, Hastings C, Zajkowska Z, Mariani N, Nikkheslat N, Sforzini L, Worrell C, Begum A, Brown M, Cleare AJ, Young AH, Pariante CM, Mondelli V. The interaction between kynurenine pathway, suicidal ideation and augmentation therapy with minocycline in patients with treatment-resistant depression. Journal of Psychopharmacology (Oxford, England). 2698811231173588. PMID 37183855 DOI: 10.1177/02698811231173588 |
0.342 |
|
| 2023 |
Sendi S, Fischer S, Papadopoulos A, Poon L, Rane LJ, Fekadu A, Mondelli V, Cleare AJ. Childhood trauma associated with increased post-awakening cortisol in major depressive disorder. Psychological Medicine. 1-6. PMID 36792953 DOI: 10.1017/S0033291723000053 |
0.665 |
|
| 2022 |
Lombardo G, Nettis MA, Hastings C, Zajkowska Z, Mariani N, Nikkheslat N, Worrell C, Enache D, McLaughlin A, Kose M, Bogdanova A, Sforzini L, Cleare AJ, Young AH, Dazzan P, et al. Sex differences in a double-blind randomized clinical trial with minocycline in treatment-resistant depressed patients: CRP and IL-6 as sex-specific predictors of treatment response. Brain, Behavior, & Immunity - Health. 26: 100561. PMID 36467125 DOI: 10.1016/j.bbih.2022.100561 |
0.374 |
|
| 2022 |
Ko K, Kopra EI, Cleare AJ, Rucker JJ. Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis. Journal of Affective Disorders. PMID 36209780 DOI: 10.1016/j.jad.2022.09.168 |
0.381 |
|
| 2022 |
Marwood L, Wise T, Kerr-Gaffney J, Strawbridge R, Williams SCR, Cleare AJ, Perkins A. Brain activity during pursuit and goal-conflict threat avoidance in major depressive disorder. Personality Neuroscience. 5: e9. PMID 36105154 DOI: 10.1017/pen.2022.1 |
0.352 |
|
| 2022 |
Scott F, Hampsey E, Gnanapragasam S, Carter B, Marwood L, Taylor RW, Emre C, Korotkova L, Martín-Dombrowski J, Cleare AJ, Young AH, Strawbridge R. Systematic review and meta-analysis of augmentation and combination treatments for early-stage treatment-resistant depression. Journal of Psychopharmacology (Oxford, England). 2698811221104058. PMID 35861202 DOI: 10.1177/02698811221104058 |
0.353 |
|
| 2022 |
McKeown L, Taylor RW, Day E, Shah R, Marwood L, Tee H, Kerr-Gaffney J, Oprea E, Geddes JR, McAllister-Williams RH, Young AH, Cleare AJ. Patient perspectives of lithium and quetiapine augmentation treatment in treatment-resistant depression: A qualitative assessment. Journal of Psychopharmacology (Oxford, England). 2698811221089042. PMID 35475375 DOI: 10.1177/02698811221089042 |
0.317 |
|
| 2022 |
Fekadu A, Demissie M, Birhane R, Medhin G, Bitew T, Hailemariam M, Minaye A, Habtamu K, Milkias B, Petersen I, Patel V, Cleare AJ, Mayston R, Thornicroft G, Alem A, et al. Under detection of depression in primary care settings in low and middle-income countries: a systematic review and meta-analysis. Systematic Reviews. 11: 21. PMID 35123556 DOI: 10.1186/s13643-022-01893-9 |
0.311 |
|
| 2021 |
Sforzini L, Worrell C, Kose M, Anderson IM, Aouizerate B, Arolt V, Bauer M, Baune BT, Blier P, Cleare AJ, Cowen PJ, Dinan TG, Fagiolini A, Ferrier IN, Hegerl U, et al. A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials. Molecular Psychiatry. PMID 34907394 DOI: 10.1038/s41380-021-01381-x |
0.324 |
|
| 2021 |
Au-Yeung SK, Griffiths J, Roberts S, Edwards C, Yu LM, Bogacz R, Rendell J, Attenburrow MJ, Watson S, Chan F, Cipriani A, Cleare A, Harmer CJ, Kessler D, Evans J, et al. PAX-D: study protocol for a randomised placebo-controlled trial evaluating the efficacy and mechanism of pramipexole as add-on treatment for people with treatment resistant depression. Evidence-Based Mental Health. PMID 34810175 DOI: 10.1136/ebmental-2021-300282 |
0.359 |
|
| 2021 |
Day E, Shah R, Taylor RW, Marwood L, Nortey K, Harvey J, McAllister-Williams RH, Geddes JR, Barrera A, Young AH, Cleare AJ, Strawbridge R. A retrospective examination of care pathways in individuals with treatment-resistant depression. Bjpsych Open. 7: e101. PMID 33988121 DOI: 10.1192/bjo.2021.59 |
0.304 |
|
| 2021 |
Markopoulou K, Fischer S, Papadopoulos A, Poon L, Rane LJ, Fekadu A, Cleare AJ. Comparison of hypothalamo-pituitary-adrenal function in treatment resistant unipolar and bipolar depression. Translational Psychiatry. 11: 244. PMID 33903590 DOI: 10.1038/s41398-021-01343-5 |
0.668 |
|
| 2021 |
Strawbridge R, Jamieson A, Hodsoll J, Ferrier IN, McAllister-Williams RH, Powell TR, Young AH, Cleare AJ, Watson S. The Role of Inflammatory Proteins in Anti-Glucocorticoid Therapy for Treatment-Resistant Depression. Journal of Clinical Medicine. 10. PMID 33669254 DOI: 10.3390/jcm10040784 |
0.335 |
|
| 2021 |
Nikolova VL, Cleare AJ, Young AH, Stone JM. Updated Review and Meta-Analysis of Probiotics for the Treatment of Clinical Depression: Adjunctive vs. Stand-Alone Treatment. Journal of Clinical Medicine. 10. PMID 33567631 DOI: 10.3390/jcm10040647 |
0.346 |
|
| 2020 |
Juruena MF, Gadelrab R, Cleare AJ, Young AH. Epigenetics: A missing link between early life stress and depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 110231. PMID 33383101 DOI: 10.1016/j.pnpbp.2020.110231 |
0.336 |
|
| 2020 |
Strawbridge R, Marwood L, King S, Young AH, Pariante CM, Colasanti A, Cleare AJ. Inflammatory Proteins and Clinical Response to Psychological Therapy in Patients with Depression: An Exploratory Study. Journal of Clinical Medicine. 9. PMID 33276697 DOI: 10.3390/jcm9123918 |
0.355 |
|
| 2020 |
Findeis H, Sauer C, Cleare A, Bauer M, Ritter P. Urothelial toxicity of esketamine in the treatment of depression. Psychopharmacology. PMID 32712681 DOI: 10.1007/S00213-020-05611-Y |
0.376 |
|
| 2020 |
Taylor RW, Marwood L, Oprea E, DeAngel V, Mather S, Valentini B, Zahn R, Young AH, Cleare AJ. Pharmacological augmentation in unipolar depression: a guide to the guidelines. The International Journal of Neuropsychopharmacology. PMID 32402075 DOI: 10.1093/Ijnp/Pyaa033 |
0.338 |
|
| 2020 |
Herane-Vives A, Young AH, Wise T, Aguirre J, de Angel V, Arnone D, Papadopoulos A, Cleare AJ. Comparison of short-term (saliva) and long-term (hair) cortisol levels in out-patients with melancholic and non-melancholic major depression. Bjpsych Open. 6: e41. PMID 32321622 DOI: 10.1192/bjo.2020.8 |
0.379 |
|
| 2020 |
Herane-Vives A, Papadopoulos A, de Angel V, Chua KC, Soto L, Chalder T, Young AH, Cleare AJ. Cortisol levels in chronic fatigue syndrome and atypical depression measured using hair and saliva specimens. Journal of Affective Disorders. 267: 307-314. PMID 32217231 DOI: 10.1016/j.jad.2020.01.146 |
0.343 |
|
| 2020 |
Herane-Vives A, Arnone D, de Angel V, Papadopoulos A, Wise T, Alameda L, Chua KC, Young AH, Cleare AJ. Cortisol levels in unmedicated patients with unipolar and bipolar major depression using hair and saliva specimens. International Journal of Bipolar Disorders. 8: 15. PMID 32133545 DOI: 10.1186/s40345-020-0180-x |
0.412 |
|
| 2020 |
Perkins AM, Bley JG, Cleare AJ, Young AH, Corr PJ, Dohrenbusch R, Ettinger U. Threat-sensitivity in affective disorders: A case-control study. Journal of Affective Disorders. 266: 595-602. PMID 32056932 DOI: 10.1016/J.Jad.2020.01.074 |
0.328 |
|
| 2020 |
Juruena MF, Eror F, Cleare AJ, Young AH. The Role of Early Life Stress in HPA Axis and Anxiety. Advances in Experimental Medicine and Biology. 1191: 141-153. PMID 32002927 DOI: 10.1007/978-981-32-9705-0_9 |
0.333 |
|
| 2020 |
Incecik E, Taylor RW, Valentini B, Hatch SL, Geddes JR, Cleare AJ, Marwood L. Online mood monitoring in treatment-resistant depression: qualitative study of patients' perspectives in the NHS. Bjpsych Bulletin. 1-7. PMID 31992374 DOI: 10.1192/bjb.2019.92 |
0.362 |
|
| 2019 |
Davies MR, Kalsi G, Armour C, Jones IR, McIntosh AM, Smith DJ, Walters JTR, Bradley JR, Kingston N, Ashford S, Beange I, Brailean A, Cleare AJ, Coleman JRI, Curtis CJ, et al. The Genetic Links to Anxiety and Depression (GLAD) Study: Online recruitment into the largest recontactable study of depression and anxiety. Behaviour Research and Therapy. 123: 103503. PMID 31715324 DOI: 10.1016/J.Brat.2019.103503 |
0.395 |
|
| 2019 |
Figaro-Drumond FV, Pereira SC, Menezes IC, von Werne Baes C, Coeli-Lacchini FB, Oliveira-Paula GH, Cleare AJ, Young AH, Tanus-Santos JE, Juruena MF, Lacchini R. Association of 11β-hydroxysteroid dehydrogenase type1 (HSD11b1) gene polymorphisms with outcome of antidepressant therapy and suicide attempts. Behavioural Brain Research. 112343. PMID 31704233 DOI: 10.1016/j.bbr.2019.112343 |
0.31 |
|
| 2019 |
Taylor RW, Marwood L, Greer B, Strawbridge R, Cleare AJ. Predictors of response to augmentation treatment in patients with treatment-resistant depression: A systematic review. Journal of Psychopharmacology (Oxford, England). 269881119872194. PMID 31526204 DOI: 10.1177/0269881119872194 |
0.341 |
|
| 2019 |
Nikolova V, Zaidi SY, Young AH, Cleare AJ, Stone JM. Gut feeling: randomized controlled trials of probiotics for the treatment of clinical depression: Systematic review and meta-analysis. Therapeutic Advances in Psychopharmacology. 9: 2045125319859963. PMID 31263542 DOI: 10.1177/2045125319859963 |
0.357 |
|
| 2019 |
Heym N, Heasman BC, Hunter K, Blanco SR, Wang GY, Siegert R, Cleare A, Gibson GR, Kumari V, Sumich AL. The role of microbiota and inflammation in self-judgement and empathy: implications for understanding the brain-gut-microbiome axis in depression. Psychopharmacology. PMID 30955108 DOI: 10.1007/S00213-019-05230-2 |
0.424 |
|
| 2019 |
Duncko R, Fischer S, Hatch SL, Frissa S, Goodwin L, Papadopoulos A, Cleare AJ, Hotopf M. Recurrence of Depression in Relation to History of Childhood Trauma and Hair Cortisol Concentration in a Community-Based Sample. Neuropsychobiology. 1-10. PMID 30897568 DOI: 10.1159/000498920 |
0.614 |
|
| 2019 |
King S, Jelen LA, Horne CM, Cleare A, Pariante CM, Young AH, Stone JM. Inflammation, Glutamate, and Cognition in Bipolar Disorder Type II: A Proof of Concept Study. Frontiers in Psychiatry. 10: 66. PMID 30881316 DOI: 10.3389/Fpsyt.2019.00066 |
0.32 |
|
| 2019 |
King S, Stone JM, Cleare A, Young AH. A systematic review on neuropsychological function in bipolar disorders type I and II and subthreshold bipolar disorders-something to think about. Cns Spectrums. 24: 127-143. PMID 30859934 DOI: 10.1017/S1092852918001463 |
0.375 |
|
| 2019 |
Palmos AB, Watson S, Hughes T, Finkelmeyer A, McAllister-Williams RH, Ferrier N, Anderson IM, Nair R, Young AH, Strawbridge R, Cleare AJ, Chung R, Frissa S, Goodwin L, Hotopf M, et al. Associations between childhood maltreatment and inflammatory markers. Bjpsych Open. 5: e3. PMID 30762500 DOI: 10.1192/Bjo.2018.80 |
0.343 |
|
| 2019 |
Fischer S, Gardini ES, Haas F, Cleare AJ. Polymorphisms in genes related to the hypothalamic-pituitary-adrenal axis and antidepressant response - Systematic review. Neuroscience and Biobehavioral Reviews. 96: 182-196. PMID 30465786 DOI: 10.1016/J.Neubiorev.2018.11.009 |
0.601 |
|
| 2019 |
Strawbridge R, Labusova A, Watson S, Cleare A. Response to anti-glucocorticoid augmentation for treatment-resistant depression: Potential role for inflammatory proteins Journal of Psychosomatic Research. 121: 117. DOI: 10.1016/J.Jpsychores.2019.03.055 |
0.408 |
|
| 2019 |
Strawbridge R, Young AH, Cleare AJ. Treatment-resistant depression: a possible 'inflammatory subtype' of depressive disorder Journal of Affective Disorders. 254: 152-153. DOI: 10.1016/J.Jad.2018.10.343 |
0.414 |
|
| 2019 |
Herane-Vives A, Arnone D, Saint-Pierre C, Aguirre J, Fischer S, Tsapekos D, Angel Vd, Papadopoulos A, Wise T, Young AH, Cleare AJ. Simultaneous assessment of cortisol levels in saliva, hair and fingernail specimens in depressive and healthy people Journal of Affective Disorders. 254: 152. DOI: 10.1016/J.Jad.2018.10.342 |
0.635 |
|
| 2019 |
Marwood L, Wise T, Patrick F, Cleare A, Perkins A. The Fake IQ test: a novel, direct measure of self-perception in major depression Journal of Affective Disorders. 254: 146. DOI: 10.1016/J.Jad.2018.10.326 |
0.406 |
|
| 2019 |
Incecik E, Taylor R, Hutchinson J, De Angel V, Opera E, Mather S, Nortey K, Geddes J, Cleare AJ, Marwood L. True Colours Monitoring in Treatment Resistant Depression: A Qualitative Study of Patients’ Perspectives Journal of Affective Disorders. 254: 142. DOI: 10.1016/J.JAD.2018.10.314 |
0.343 |
|
| 2019 |
Taylor R, Marwood L, Greer B, Strawbridge R, Cleare AJ. Predictors of response to treatment augmentation in patients with treatment resistant depression: a systematic review Journal of Affective Disorders. 254: 141. DOI: 10.1016/J.JAD.2018.10.312 |
0.352 |
|
| 2019 |
DeAngel V, Marwood L, Oprea E, Valentini B, Mather S, Taylor R, Cleare A. Review of prescribing and monitoring guidelines for first and second line pharmacological augmentation therapies in treatment resistant depression Journal of Affective Disorders. 254: 131. DOI: 10.1016/J.Jad.2018.10.287 |
0.402 |
|
| 2019 |
Herane-Vives A, Young AH, Wise T, Aguirre J, Angel Vd, Arnone D, Tsapekos D, Papadopoulos A, Cleare AJ. A comparison of short- and long-term cortisol levels in melancholic and non-melancholic major depressive episodes using hair and saliva specimens Journal of Affective Disorders. 254: 127-128. DOI: 10.1016/J.Jad.2018.10.278 |
0.336 |
|
| 2018 |
Strawbridge R, Hodsoll J, Powell TR, Hotopf M, Hatch SL, Breen G, Cleare AJ. Inflammatory profiles of severe treatment-resistant depression. Journal of Affective Disorders. 246: 42-51. PMID 30578945 DOI: 10.1016/J.Jad.2018.12.037 |
0.375 |
|
| 2018 |
Russell A, Hepgul N, Nikkheslat N, Borsini A, Zajkowska Z, Moll N, Forton D, Agarwal K, Chalder T, Mondelli V, Hotopf M, Cleare A, Murphy G, Foster G, Wong T, et al. Persistent fatigue induced by interferon-alpha: a novel, inflammation-based, proxy model of chronic fatigue syndrome. Psychoneuroendocrinology. PMID 30567628 DOI: 10.1016/J.Psyneuen.2018.11.032 |
0.31 |
|
| 2018 |
Strawbridge R, Carter B, Marwood L, Bandelow B, Tsapekos D, Nikolova VL, Taylor R, Mantingh T, de Angel V, Patrick F, Cleare AJ, Young AH. Augmentation therapies for treatment-resistant depression: systematic review and meta-analysis - CORRIGENDUM. The British Journal of Psychiatry : the Journal of Mental Science. 1. PMID 30566398 DOI: 10.1192/bjp.2018.291 |
0.313 |
|
| 2018 |
Hidalgo-Mazzei D, Berk M, Cipriani A, Cleare AJ, Florio AD, Dietch D, Geddes JR, Goodwin GM, Grunze H, Hayes JF, Jones I, Kasper S, Macritchie K, McAllister-Williams RH, Morriss R, et al. Treatment-resistant and multi-therapy-resistant criteria for bipolar depression: consensus definition. The British Journal of Psychiatry : the Journal of Mental Science. 1-9. PMID 30520709 DOI: 10.1192/Bjp.2018.257 |
0.416 |
|
| 2018 |
Strawbridge R, Carter B, Marwood L, Bandelow B, Tsapekos D, Nikolova VL, Taylor R, Mantingh T, de Angel V, Patrick F, Cleare AJ, Young AH. Augmentation therapies for treatment-resistant depression: systematic review and meta-analysis. The British Journal of Psychiatry : the Journal of Mental Science. 1-10. PMID 30457075 DOI: 10.1192/bjp.2018.233 |
0.345 |
|
| 2018 |
Fischer S, King S, Papadopoulos A, Hotopf M, Young AH, Cleare AJ. Hair cortisol and childhood trauma predict psychological therapy response in depression and anxiety disorders. Acta Psychiatrica Scandinavica. PMID 30302747 DOI: 10.1111/Acps.12970 |
0.658 |
|
| 2018 |
Pisoni A, Strawbridge R, Hodsoll J, Powell TR, Breen G, Hatch S, Hotopf M, Young AH, Cleare AJ. Growth Factor Proteins and Treatment-Resistant Depression: A Place on the Path to Precision. Frontiers in Psychiatry. 9: 386. PMID 30190686 DOI: 10.3389/fpsyt.2018.00386 |
0.376 |
|
| 2018 |
Wise T, Taylor MJ, Herane-Vives A, Gammazza AM, Cappello F, Lythgoe DJ, Williams SC, Young AH, Cleare AJ, Arnone D. Glutamatergic hypofunction in medication-free major depression: Secondary effects of affective diagnosis and relationship to peripheral glutaminase. Journal of Affective Disorders. 234: 214-219. PMID 29544167 DOI: 10.1016/j.jad.2018.02.059 |
0.355 |
|
| 2018 |
van Belkum SM, Geugies HH, Lysen TS, Cleare AJ, Peeters FPML, Penninx BWJH, Schoevers RA, Ruhe EG. Validity of the Maudsley Staging Method in Predicting Treatment-Resistant Depression Outcome Using the Netherlands Study of Depression and Anxiety. The Journal of Clinical Psychiatry. 79. PMID 29370485 DOI: 10.4088/Jcp.17M11475 |
0.387 |
|
| 2017 |
Herane-Vives A, Fischer S, de Angel V, Wise T, Cheung E, Chua KC, Arnone D, Young AH, Cleare AJ. Elevated fingernail cortisol levels in major depressive episodes. Psychoneuroendocrinology. 88: 17-23. PMID 29153629 DOI: 10.1016/J.Psyneuen.2017.10.026 |
0.658 |
|
| 2017 |
Fischer S, Macare C, Cleare AJ. Hypothalamic-pituitary-adrenal (HPA) axis functioning as predictor of antidepressant response-Meta-analysis. Neuroscience and Biobehavioral Reviews. 83: 200-211. PMID 29032090 DOI: 10.1016/J.Neubiorev.2017.10.012 |
0.633 |
|
| 2017 |
Strawbridge R, Young AH, Cleare AJ. Biomarkers for depression: recent insights, current challenges and future prospects. Neuropsychiatric Disease and Treatment. 13: 1245-1262. PMID 28546750 DOI: 10.2147/NDT.S114542 |
0.37 |
|
| 2017 |
Wise T, Marwood L, Perkins AM, Herane-Vives A, Joules R, Lythgoe DJ, Luh WM, Williams SCR, Young AH, Cleare AJ, Arnone D. Instability of default mode network connectivity in major depression: a two-sample confirmation study. Translational Psychiatry. 7: e1105. PMID 28440813 DOI: 10.1038/Tp.2017.40 |
0.462 |
|
| 2017 |
Herane-Vives A, Cleare AJ, Chang CK, de Angel V, Papadopoulos A, Fischer S, Halari R, Cheung EY, Young AH. Cortisol levels in fingernails, neurocognitive performance and clinical variables in euthymic bipolar I disorder. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-12. PMID 28345388 DOI: 10.1080/15622975.2017.1298838 |
0.576 |
|
| 2017 |
Fischer S, Cleare AJ. Cortisol as a predictor of psychological therapy response in anxiety disorders-Systematic review and meta-analysis. Journal of Anxiety Disorders. 47: 60-68. PMID 28273494 DOI: 10.1016/J.Janxdis.2017.02.007 |
0.604 |
|
| 2017 |
Herane A, Wise T, Angel VD, Arnone D, Tsapekos D, Papadopoulos A, Young A, Cleare A. Cortisol levels in typical and non-typical major depressive episodes, using hair and saliva specimens Frontiers in Psychiatry. 8. DOI: 10.3389/Conf.Fpsyt.2017.48.00022 |
0.503 |
|
| 2017 |
Juruena M, Castro M, Graeff F, Cleare A, Young A. Mineralocorticoid Receptor Agonist as a Predictor of Treatment Outcome in Depression with and without Early Life Stress Frontiers in Psychiatry. 8. DOI: 10.3389/Conf.Fpsyt.2017.48.00013 |
0.39 |
|
| 2017 |
Fischer S, King S, Papadopoulos A, Hotopf M, Young AH, Cleare AJ. Hair cortisol as predictor of psychotherapy response in affective disorders Psychoneuroendocrinology. 83: 46. DOI: 10.1016/J.Psyneuen.2017.07.364 |
0.554 |
|
| 2017 |
Vives AH, Wise T, Angel VD, Arnone D, Tsapekos D, Papadopoulos A, Young A, Cleare A. Cortisol levels in typical and non-typical major depressive episodes, using hair and saliva specimens Psychoneuroendocrinology. 83: 44-45. DOI: 10.1016/J.Psyneuen.2017.07.359 |
0.503 |
|
| 2017 |
Wise T, Marwood L, Adam P, Herane-Vives A, Williams S, Young A, Cleare A, Arnone D. 265. Morphometric Correlates of Bipolarity in Major Depression Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.279 |
0.489 |
|
| 2016 |
Fischer S, Duncko R, Hatch SL, Papadopoulos A, Goodwin L, Frissa S, Hotopf M, Cleare AJ. Sociodemographic, lifestyle, and psychosocial determinants of hair cortisol in a South London community sample. Psychoneuroendocrinology. 76: 144-153. PMID 27923182 DOI: 10.1016/J.Psyneuen.2016.11.011 |
0.571 |
|
| 2016 |
Fischer S, Strawbridge R, Herane Vives A, Cleare AJ. Cortisol as a predictor of psychological therapy response in depressive disorders: systematic review and meta-analysis. The British Journal of Psychiatry : the Journal of Mental Science. PMID 27908897 DOI: 10.1192/Bjp.Bp.115.180653 |
0.638 |
|
| 2016 |
Hepgul N, Pariante CM, Baraldi S, Borsini A, Bufalino C, Russell A, Agarwal K, Cleare AJ, Forton DM, Henderson M, Mondelli V, Ranjith G, Hotopf M. Depression and anxiety in patients receiving interferon-alpha: The role of illness perceptions. Journal of Health Psychology. PMID 27458106 DOI: 10.1177/1359105316658967 |
0.308 |
|
| 2016 |
Hepgul N, King S, Amarasinghe M, Breen G, Grant N, Grey N, Hotopf M, Moran P, Pariante CM, Tylee A, Wingrove J, Young AH, Cleare AJ. Clinical characteristics of patients assessed within an Improving Access to Psychological Therapies (IAPT) service: results from a naturalistic cohort study (Predicting Outcome Following Psychological Therapy; PROMPT). Bmc Psychiatry. 16: 52. PMID 26920578 DOI: 10.1186/S12888-016-0736-6 |
0.306 |
|
| 2016 |
Marwood L, Perkins AM, Cleare AJ, Wise TPJ. A meta-analysis of the neural effects of psychotherapy in depression and anxiety disorders Bipolar Disorders. 109-110. DOI: 10.1111/Bdi.12407/Full |
0.383 |
|
| 2016 |
Fischer S, Duncko R, Papadopoulos A, Hatch SL, Hotopf M, Cleare AJ. Sociodemographic, lifestyle, and psychosocial determinants of hair cortisol – Evidence from a south London community sample Psychoneuroendocrinology. 71: 74. DOI: 10.1016/j.psyneuen.2016.07.192 |
0.492 |
|
| 2016 |
Herane-Vives A, Chang C-, Papadopoulos A, Angel VD, Wise T, Chua C, Young AH, Cleare A. Long-term pattern of cortisol secretion in patients with depression, chronic fatigue syndrome and healthy controls Psychoneuroendocrinology. 71: 62. DOI: 10.1016/J.Psyneuen.2016.07.161 |
0.444 |
|
| 2016 |
Herane-Vives A, Angel VD, Wise T, Chang C, Papadopoulos A, Arnone D, Young A, Cleare A. Cortisol levels in unipolar and bipolar depression using hair and saliva specimens Psychoneuroendocrinology. 71: 21-22. DOI: 10.1016/J.Psyneuen.2016.07.063 |
0.512 |
|
| 2016 |
Herane-Vives A, Fischer S, Angel VD, Wise T, Papadopoulos A, Arnone D, Young A, Cleare A. Cortisol levels in major depressive episode using fingernail specimens Psychoneuroendocrinology. 71: 21. DOI: 10.1016/J.Psyneuen.2016.07.062 |
0.677 |
|
| 2016 |
Herane-Vives A, Angel VD, Chalder T, Soto L, Chua K, Young AH, Cleare A. Cortisol levels in atypical depression and chronic fatigue syndrome using hair and saliva specimens Psychoneuroendocrinology. 71: 21. DOI: 10.1016/J.Psyneuen.2016.07.061 |
0.47 |
|
| 2016 |
Herane-Vives A, Angel VD, Wise T, Chang C, Young AH, Arnone D, Cleare A. Cortisol levels in atypical and non-atypical depression using hair and saliva specimens Psychoneuroendocrinology. 71: 20. DOI: 10.1016/J.Psyneuen.2016.07.060 |
0.496 |
|
| 2016 |
Cleare AJ, Duncko R. Pharmacological management of depressive disorders Medicine. 44: 756-760. DOI: 10.1016/J.MPMED.2016.09.004 |
0.357 |
|
| 2015 |
Suzuki A, Poon L, Kumari V, Cleare AJ. Fear Biases in Emotional Face Processing Following Childhood Trauma as a Marker of Resilience and Vulnerability to Depression. Child Maltreatment. 20: 240-50. PMID 26294753 DOI: 10.1177/1077559515600781 |
0.379 |
|
| 2015 |
Strawbridge R, Arnone D, Danese A, Papadopoulos A, Herane Vives A, Cleare AJ. Inflammation and clinical response to treatment in depression: A meta-analysis. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 25: 1532-43. PMID 26169573 DOI: 10.1016/J.Euroneuro.2015.06.007 |
0.447 |
|
| 2015 |
Cleare A, Pariante CM, Young AH, Anderson IM, Christmas D, Cowen PJ, Dickens C, Ferrier IN, Geddes J, Gilbody S, Haddad PM, Katona C, Lewis G, Malizia A, McAllister-Williams RH, et al. Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines. Journal of Psychopharmacology (Oxford, England). 29: 459-525. PMID 25969470 DOI: 10.1177/0269881115581093 |
0.445 |
|
| 2015 |
Wise T, Radua J, Nortje G, Cleare AJ, Young AH, Arnone D. Voxel-Based Meta-Analytical Evidence of Structural Disconnectivity in Major Depression and Bipolar Disorder. Biological Psychiatry. PMID 25891219 DOI: 10.1016/J.Biopsych.2015.03.004 |
0.341 |
|
| 2015 |
Herane A, Papadopoulos A, King S, Chang CK, Cheung E, Halari R, Angel VD, Cleare A, Young AH. P.2.d.001 Cortisol levels in nails and neurocognitive performance in euthymic bipolar I patients and healthy controls European Neuropsychopharmacology. 25. DOI: 10.1016/S0924-977X(15)30543-5 |
0.317 |
|
| 2015 |
Fischer S, Cleare A. HPA axis functioning as a predictor of psychotherapy response in patients with depression and anxiety disorders – A systematic review and meta-analysis Psychoneuroendocrinology. 61: 23-24. DOI: 10.1016/J.Psyneuen.2015.07.454 |
0.677 |
|
| 2014 |
Suzuki A, Poon L, Papadopoulos AS, Kumari V, Cleare AJ. Long term effects of childhood trauma on cortisol stress reactivity in adulthood and relationship to the occurrence of depression. Psychoneuroendocrinology. 50: 289-99. PMID 25265282 DOI: 10.1016/j.psyneuen.2014.09.007 |
0.329 |
|
| 2014 |
Wise T, Cleare AJ, Herane A, Young AH, Arnone D. Diagnostic and therapeutic utility of neuroimaging in depression: an overview. Neuropsychiatric Disease and Treatment. 10: 1509-22. PMID 25187715 DOI: 10.2147/NDT.S50156 |
0.345 |
|
| 2014 |
Grant N, Hotopf M, Breen G, Cleare A, Grey N, Hepgul N, King S, Moran P, Pariante CM, Wingrove J, Young AH, Tylee A. Predicting outcome following psychological therapy in IAPT (PROMPT): a naturalistic project protocol. Bmc Psychiatry. 14: 170. PMID 24910361 DOI: 10.1186/1471-244X-14-170 |
0.455 |
|
| 2014 |
Tunnard C, Rane LJ, Wooderson SC, Markopoulou K, Poon L, Fekadu A, Juruena M, Cleare AJ. The impact of childhood adversity on suicidality and clinical course in treatment-resistant depression. Journal of Affective Disorders. 152: 122-30. PMID 23880448 DOI: 10.1016/j.jad.2013.06.037 |
0.358 |
|
| 2014 |
Suzuki A, Kumari V, Poon L, Cleare A. EPA-0453 – Processing bias of facial emotions as a function of childhood trauma: resilience and vulnerability to depression European Psychiatry. 29: 1. DOI: 10.1016/S0924-9338(14)77871-X |
0.424 |
|
| 2013 |
Juruena MF, Pariante CM, Papadopoulos AS, Poon L, Lightman S, Cleare AJ. The role of mineralocorticoid receptor function in treatment-resistant depression. Journal of Psychopharmacology (Oxford, England). 27: 1169-79. PMID 23904409 DOI: 10.1177/0269881113499205 |
0.339 |
|
| 2013 |
Vergunst FK, Fekadu A, Wooderson SC, Tunnard CS, Rane LJ, Markopoulou K, Cleare AJ. Longitudinal course of symptom severity and fluctuation in patients with treatment-resistant unipolar and bipolar depression. Psychiatry Research. 207: 143-9. PMID 23601791 DOI: 10.1016/j.psychres.2013.03.022 |
0.379 |
|
| 2013 |
Carvalho LA, Torre JP, Papadopoulos AS, Poon L, Juruena MF, Markopoulou K, Cleare AJ, Pariante CM. Lack of clinical therapeutic benefit of antidepressants is associated overall activation of the inflammatory system. Journal of Affective Disorders. 148: 136-40. PMID 23200297 DOI: 10.1016/J.Jad.2012.10.036 |
0.444 |
|
| 2012 |
Rane LJ, Fekadu A, Papadopoulos AS, Wooderson SC, Poon L, Markopoulou K, Cleare AJ. Psychological and physiological effects of caring for patients with treatment-resistant depression. Psychological Medicine. 42: 1825-33. PMID 22251699 DOI: 10.1017/S0033291711003035 |
0.466 |
|
| 2012 |
Szu-Ting Fu T, Koutstaal W, Poon L, Cleare AJ. Confidence judgment in depression and dysphoria: the depressive realism vs. negativity hypotheses. Journal of Behavior Therapy and Experimental Psychiatry. 43: 699-704. PMID 22071004 DOI: 10.1016/J.Jbtep.2011.09.014 |
0.401 |
|
| 2012 |
Papadopoulos AS, Cleare AJ. Hypothalamic-pituitary-adrenal axis dysfunction in chronic fatigue syndrome. Nature Reviews. Endocrinology. 8: 22-32. PMID 21946893 DOI: 10.1038/nrendo.2011.153 |
0.304 |
|
| 2010 |
Juruena MF, Cleare AJ, Papadopoulos AS, Poon L, Lightman S, Pariante CM. The prednisolone suppression test in depression: dose-response and changes with antidepressant treatment. Psychoneuroendocrinology. 35: 1486-91. PMID 20558006 DOI: 10.1016/J.Psyneuen.2010.04.016 |
0.391 |
|
| 2010 |
Rane LJ, Fekadu A, Wooderson S, Poon L, Markopoulou K, Cleare AJ. Discrepancy between subjective and objective severity in treatment-resistant depression: prediction of treatment outcome. Journal of Psychiatric Research. 44: 1082-7. PMID 20471031 DOI: 10.1016/J.Jpsychires.2010.03.020 |
0.486 |
|
| 2010 |
Cole J, Toga AW, Hojatkashani C, Thompson P, Costafreda SG, Cleare AJ, Williams SC, Bullmore ET, Scott JL, Mitterschiffthaler MT, Walsh ND, Donaldson C, Mirza M, Marquand A, Nosarti C, et al. Subregional hippocampal deformations in major depressive disorder. Journal of Affective Disorders. 126: 272-7. PMID 20392498 DOI: 10.1016/J.Jad.2010.03.004 |
0.402 |
|
| 2010 |
Roberts A, Charler ML, Papadopoulos A, Wessely S, Chalder T, Cleare A. Does hypocortisolism predict a poor response to cognitive behavioural therapy in chronic fatigue syndrome Psychological Medicine. 40: 515-522. PMID 19607750 DOI: 10.1017/S0033291709990390 |
0.35 |
|
| 2010 |
Juruena MF, Pariante C, Papadopoulos AS, Poon L, Lightman S, Cleare A. P.2.a.031 Prednisolone suppression test, but not dexamethasone predicts outcome in treatment resistant depression European Neuropsychopharmacology. 20. DOI: 10.1016/S0924-977X(10)70487-9 |
0.398 |
|
| 2010 |
Carvalho L, Torre J, Cleare A, Pariante C. P.2.a.016 Cytokine profile in treatment-resistant depression European Neuropsychopharmacology. 20: S342-S343. DOI: 10.1016/S0924-977X(10)70472-7 |
0.33 |
|
| 2010 |
Markopoulou⁎ K, Papadopoulos A, Poon L, Cleare A. The salivary ratio of cortisol/DHEA in treatment resistant unipolar depression Journal of Affective Disorders. 122: S72. DOI: 10.1016/J.Jad.2010.02.105 |
0.467 |
|
| 2010 |
Markopoulou⁎ K, Papadopoulos A, Poon L, Cleare A. The cortisol awakening response (CAR) in treatment resistant unipolar depression Journal of Affective Disorders. 122: S72. DOI: 10.1016/j.jad.2010.02.104 |
0.379 |
|
| 2009 |
Datta V, Cleare AJ. Recent advances in bipolar disorder pharmacotherapy: focus on bipolar depression and rapid cycling. Expert Review of Clinical Pharmacology. 2: 423-34. PMID 22112185 DOI: 10.1586/ecp.09.10 |
0.345 |
|
| 2009 |
Juruena MF, Pariante CM, Papadopoulos AS, Poon L, Lightman S, Cleare AJ. Prednisolone suppression test in depression: prospective study of the role of HPA axis dysfunction in treatment resistance. The British Journal of Psychiatry : the Journal of Mental Science. 194: 342-9. PMID 19336786 DOI: 10.1192/Bjp.Bp.108.050278 |
0.432 |
|
| 2009 |
Fekadu A, Wooderson S, Donaldson C, Markopoulou K, Masterson B, Poon L, Cleare AJ. A multidimensional tool to quantify treatment resistance in depression: the Maudsley staging method. The Journal of Clinical Psychiatry. 70: 177-84. PMID 19192471 DOI: 10.4088/JCP.08m04309 |
0.303 |
|
| 2009 |
Halari R, Simic M, Pariante CM, Papadopoulos A, Cleare A, Brammer M, Fombonne E, Rubia K. Reduced activation in lateral prefrontal cortex and anterior cingulate during attention and cognitive control functions in medication-naïve adolescents with depression compared to controls. Journal of Child Psychology and Psychiatry, and Allied Disciplines. 50: 307-16. PMID 19175815 DOI: 10.1111/J.1469-7610.2008.01972.X |
0.317 |
|
| 2009 |
Fekadu A, Wooderson SC, Markopoulo K, Donaldson C, Papadopoulos A, Cleare AJ. What happens to patients with treatment-resistant depression? A systematic review of medium to long term outcome studies. Journal of Affective Disorders. 116: 4-11. PMID 19007996 DOI: 10.1016/j.jad.2008.10.014 |
0.331 |
|
| 2009 |
Markopoulou K, Papadopoulos A, Juruena MF, Poon L, Pariante CM, Cleare AJ. The ratio of cortisol/DHEA in treatment resistant depression. Psychoneuroendocrinology. 34: 19-26. PMID 18805642 DOI: 10.1016/j.psyneuen.2008.08.004 |
0.366 |
|
| 2009 |
Bull SJ, Huezo-Diaz P, Binder EB, Cubells JF, Ranjith G, Maddock C, Miyazaki C, Alexander N, Hotopf M, Cleare AJ, Norris S, Cassidy E, Aitchison KJ, Miller AH, Pariante CM. Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment. Molecular Psychiatry. 14: 1095-104. PMID 18458677 DOI: 10.1038/Mp.2008.48 |
0.378 |
|
| 2009 |
Fekadu A, Cleare AJ. Reply to Pseudoresistant Bipolar Depression The Journal of Clinical Psychiatry. 70: 1477. DOI: 10.4088/JCP.09LR05181AGRE |
0.406 |
|
| 2009 |
Datta V, Cleare AJ. Recent advances in bipolar disorder pharmacotherapy: Focus on bipolar depression and rapid cycling Expert Review of Clinical Pharmacology. 2: 423-434. DOI: 10.1586/ecp.09.10 |
0.342 |
|
| 2009 |
Bull S, Heuzo-Diaz P, Binder E, Cubells J, Ranjith G, Maddock C, Hotopf M, Norris S, Cassidy E, Aitchison K, Cleare A, Miller A, Pariante C. 16. IL-10 genetic variants and hepatitis C patients’ symptoms of depression and fatigue before and during Interferon-alpha treatment Brain, Behavior, and Immunity. 23: S29. DOI: 10.1016/J.Bbi.2009.06.021 |
0.365 |
|
| 2008 |
Cleare A. Adjunctive aripiprazole improves symptoms in antidepressant refractory major depressive disorder. Evidence-Based Mental Health. 11: 111. PMID 18952960 DOI: 10.1136/Ebmh.11.4.111 |
0.482 |
|
| 2008 |
Marquand AF, Mourão-Miranda J, Brammer MJ, Cleare AJ, Fu CH. Neuroanatomy of verbal working memory as a diagnostic biomarker for depression. Neuroreport. 19: 1507-11. PMID 18797307 DOI: 10.1097/Wnr.0B013E328310425E |
0.307 |
|
| 2008 |
Fu CH, Williams SC, Cleare AJ, Scott J, Mitterschiffthaler MT, Walsh ND, Donaldson C, Suckling J, Andrew C, Steiner H, Murray RM. Neural responses to sad facial expressions in major depression following cognitive behavioral therapy. Biological Psychiatry. 64: 505-12. PMID 18550030 DOI: 10.1016/J.Biopsych.2008.04.033 |
0.358 |
|
| 2008 |
Carvalho LA, Juruena MF, Papadopoulos AS, Poon L, Kerwin R, Cleare AJ, Pariante CM. Clomipramine in vitro reduces glucocorticoid receptor function in healthy subjects but not in patients with major depression Neuropsychopharmacology. 33: 3182-3189. PMID 18368033 DOI: 10.1038/Npp.2008.44 |
0.365 |
|
| 2008 |
Mitterschiffthaler MT, Williams S, Walsh ND, Donaldson C, Scott J, Cleare A, Steiner H, Fu C. Functional imaging of neural responses to emotional interference before and after cognitive behavioural therapy in major depression European Psychiatry. 23. DOI: 10.1016/J.Eurpsy.2008.01.1038 |
0.391 |
|
| 2007 |
Juruena MF, Cleare AJ. [Overlap between atypical depression, seasonal affective disorder and chronic fatigue syndrome]. Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999). 29: S19-26. PMID 17546343 |
0.433 |
|
| 2007 |
Fekadu A, Alem A, Medhin G, Shibre T, Cleare A, Prince M, Kebede D. Utility of the concept of minor depressive disorder: evidence from a large rural community sample in a developing country setting. Journal of Affective Disorders. 104: 111-8. PMID 17448542 DOI: 10.1016/J.Jad.2007.03.008 |
0.44 |
|
| 2007 |
Fu CH, Williams SC, Brammer MJ, Suckling J, Kim J, Cleare AJ, Walsh ND, Mitterschiffthaler MT, Andrew CM, Pich EM, Bullmore ET. Neural responses to happy facial expressions in major depression following antidepressant treatment. The American Journal of Psychiatry. 164: 599-607. PMID 17403973 DOI: 10.1176/Ajp.2007.164.4.599 |
0.368 |
|
| 2007 |
Juruena M, Cleare A, Papadopoulos A, Poon L, Lightman S, Pariante C. P.2.a.033 Treatment resistant depression: prednisolone suppression test predicts response to inpatient treatment European Neuropsychopharmacology. 17: S330-S331. DOI: 10.1016/S0924-977X(07)70475-3 |
0.308 |
|
| 2006 |
Juruena MF, Cleare AJ, Papadopoulos AS, Poon L, Lightman S, Pariante CM. Different responses to dexamethasone and prednisolone in the same depressed patients. Psychopharmacology. 189: 225-35. PMID 17016711 DOI: 10.1007/S00213-006-0555-4 |
0.428 |
|
| 2005 |
Jerjes WK, Cleare A, Wessely S, Wood PJ, Taylor NF. Diurnal patterns of salivary cortisol and cortisone output in chronic fatigue syndrome. Journal of Affective Disorders. 87: 299-304. PMID 15922454 DOI: 10.1016/J.Jad.2005.03.013 |
0.364 |
|
| 2005 |
Rubin GJ, Hotopf M, Papadopoulos A, Cleare A. Salivary cortisol as a predictor of postoperative fatigue. Psychosomatic Medicine. 67: 441-7. PMID 15911908 DOI: 10.1097/01.Psy.0000161207.73744.4E |
0.306 |
|
| 2005 |
Juruena M, Cleare A, Papadopoulos A, Poon L, Lightman S, Pariante C. P.4.10 Different response to a dexamethasone and prednisolone test in treatment-resistant depressed patients European Neuropsychopharmacology. 15. DOI: 10.1016/S0924-977X(05)80203-2 |
0.457 |
|
| 2005 |
Fu T, Koutstaal W, Fu CHY, Poon L, Cleare AJ. Depression, confidence, and decision: Evidence against depressive realism Journal of Psychopathology and Behavioral Assessment. 27: 243-252. DOI: 10.1007/S10862-005-2404-X |
0.388 |
|
| 2004 |
Juruena MF, Cleare AJ, Pariante CM. [The hypothalamic pituitary adrenal axis, glucocorticoid receptor function and relevance to depression]. Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999). 26: 189-201. PMID 15645065 DOI: 10.1590/s1516-44462004000300009 |
0.374 |
|
| 2004 |
Fu CH, Williams SC, Cleare AJ, Brammer MJ, Walsh ND, Kim J, Andrew CM, Pich EM, Williams PM, Reed LJ, Mitterschiffthaler MT, Suckling J, Bullmore ET. Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. Archives of General Psychiatry. 61: 877-89. PMID 15351766 DOI: 10.1001/Archpsyc.61.9.877 |
0.377 |
|
| 2004 |
Cleare AJ, O'Keane V, Miell JP. Levels of DHEA and DHEAS and responses to CRH stimulation and hydrocortisone treatment in chronic fatigue syndrome. Psychoneuroendocrinology. 29: 724-32. PMID 15110921 DOI: 10.1016/S0306-4530(03)00104-5 |
0.379 |
|
| 2004 |
Cleare A, Roberts A, Papadopoulos A, Chalder T, Wessely S. P.6.077 Cognitive behavioural therapy normalises HPA axis dysfunction in chronic fatigue syndrome European Neuropsychopharmacology. 14. DOI: 10.1016/S0924-977X(04)80581-9 |
0.392 |
|
| 2003 |
Juruena MF, Cleare AJ, Bauer ME, Pariante CM. Molecular mechanisms of glucocorticoid receptor sensitivity and relevance to affective disorders. Acta Neuropsychiatrica. 15: 354-67. PMID 26983771 DOI: 10.1046/J.1601-5215.2003.00051.X |
0.401 |
|
| 2003 |
Lee W, Cleare A. Lithium augmentation in treatment-refractory unipolar depression. The British Journal of Psychiatry : the Journal of Mental Science. 182: 456; author reply 45. PMID 12724254 DOI: 10.1192/Bjp.182.5.456 |
0.344 |
|
| 2002 |
Skowera A, Stewart E, Davis ET, Cleare AJ, Unwin C, Hull L, Ismail K, Hossain G, Wessely SC, Peakman M. Antinuclear autoantibodies (ANA) in Gulf War-related illness and chronic fatigue syndrome (CFS) patients. Clinical and Experimental Immunology. 129: 354-8. PMID 12165094 DOI: 10.1046/J.1365-2249.2002.01912.X |
0.328 |
|
| 2001 |
Stanton BR, David AS, Cleare AJ, Sierra M, Lambert MV, Phillips ML, Porter RJ, Gallagher P, Young AH. Basal activity of the hypothalamic-pituitary-adrenal axis in patients with depersonalization disorder. Psychiatry Research. 104: 85-9. PMID 11600192 DOI: 10.1016/S0165-1781(01)00291-8 |
0.37 |
|
| 2001 |
Cleare AJ, Miell J, Heap E, Sookdeo S, Young L, Malhi GS, O'Keane V. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy. The Journal of Clinical Endocrinology and Metabolism. 86: 3545-54. PMID 11502777 DOI: 10.1210/Jcem.86.8.7735 |
0.36 |
|
| 2001 |
Skowera A, Peakman M, Cleare A, Davies E, Deale A, Wessely S. High prevalence of serum markers of coeliac disease in patients with chronic fatigue syndrome. Journal of Clinical Pathology. 54: 335-336. PMID 11304857 DOI: 10.1136/Jcp.54.4.335-A |
0.311 |
|
| 1999 |
Wingrove J, Bond AJ, Cleare AJ, Sherwood R. Plasma tryptophan and trait aggression. Journal of Psychopharmacology (Oxford, England). 13: 235-7. PMID 10512077 DOI: 10.1177/026988119901300304 |
0.308 |
|
| 1998 |
Cleare A, Murray R, Sherwood R, O'Keane V. Abnormal 5-HT1D receptor function in major depression : a neuropharmacological challenge study using sumatriptan Psychological Medicine. 28: 295-300. PMID 9572087 DOI: 10.1017/S003329179700634X |
0.409 |
|
| 1998 |
Cleare AJ, Murray RM, O'Keane V. Do noradrenergic reuptake inhibitors affect serotonergic function in depression? Psychopharmacology. 134: 406-10. PMID 9452184 DOI: 10.1007/S002130050478 |
0.453 |
|
| 1998 |
Cleare A. Chronic fatigue syndrome, serotonin and depression: How strong the link? European Psychiatry. 13: 141s-141s. DOI: 10.1016/S0924-9338(99)80036-4 |
0.355 |
|
| 1997 |
Abel KM, O'Keane V, Murray RM, Cleare AJ. Serotonergic function and negative and depressive symptomatology in schizophrenia and major depression. Psychoneuroendocrinology. 22: 539-48. PMID 9373887 DOI: 10.1016/S0306-4530(97)00050-4 |
0.333 |
|
| 1997 |
Cleare AJ. Reduced whole blood serotonin in major depression. Depression and Anxiety. 5: 108-11. PMID 9262942 DOI: 10.1002/(SICI)1520-6394(1997)5:2<108::AID-DA8>3.0.CO;2-B |
0.39 |
|
| 1996 |
Cleare AJ, McGregor A, O'Keane V. Neuroendocrine evidence for an association between hypothyroidism, reduced central 5-HT activity and depression. Clinical Endocrinology. 43: 713-9. PMID 8736274 DOI: 10.1111/J.1365-2265.1995.Tb00540.X |
0.439 |
|
| 1996 |
Cleare AJ, Murray RM, O'Keane V. Reduced prolactin and cortisol responses to d-fenfluramine in depressed compared to healthy matched control subjects. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 14: 349-54. PMID 8703303 DOI: 10.1016/0893-133X(95)00144-3 |
0.322 |
|
| 1996 |
Cleare AJ, Bearn J, Allain T, McGregor A, Wessely S, Murray RM, O'Keane V. Contrasting neuroendocrine responses in depression and chronic fatigue syndrome. Journal of Affective Disorders. 34: 283-9. PMID 8550954 DOI: 10.1016/0165-0327(95)00026-J |
0.418 |
|
| 1996 |
Cleare AJ, McGregor A, Chambers SM, Dawling S, O’Keane V. Thyroxine Replacement Increases Central 5-Hydroxytryptamine Activity and Reduces Depressive Symptoms in Hypothyroidism Neuroendocrinology. 64: 65-69. DOI: 10.1159/000127099 |
0.329 |
|
| 1996 |
Cleare A, Murray R, O’Keane V. D-Fenfluramine responses in depression before and after antidepressant treatment European Psychiatry. 11: 337s. DOI: 10.1016/0924-9338(96)89057-2 |
0.367 |
|
| 1996 |
Cleare A, Abel K, O’Keane V. Pharmacological evidence that depressive symptoms do not share a common serotonergic mechanism across diagnoses European Psychiatry. 11: 292s-293s. DOI: 10.1016/0924-9338(96)88891-2 |
0.344 |
|
| 1995 |
Cleare AJ, Bearn J, McGregor A, Allain T, Wessely S, Murray RM, O'Keane V. Contrasting neuroendocrine responses in depression and chronic fatigue syndrome Biological Psychiatry. 37: 655. DOI: 10.1016/0006-3223(95)94634-9 |
0.418 |
|
| Show low-probability matches. |